Brief: Onxeo receives USPTO Notice Of Allowance for a new AsiDNATM-related patent

Valerio Therapeutics SA

13/02/2017 17:01

Feb 13 (Reuters) - Onxeo  C4X.PA : 
    * Receives USPTO Notice Of Allowance for a new 
asiDNATM-related patent, expanding its IP protection in the U.S. 
    * This newly allowed patent will expire in mid-2031 
    * The term of the patent could be further extended to 2036 
through patent term extension (PTE) 
 
Source text for Eikon:  ID:nBw9z4fWTa  
Further company coverage:  C4X.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))